EBV-related malignancies such as Burkitt lymphoma, Hodgkin's disease, and nasopharyngeal carcinoma typically express EBV nuclear antigen 1 (EBNA1) and varying levels of latent membrane protein 2 (LMP2) [1]. The gene discussed is PSMB9; the disease is nasopharyngeal carcinoma.